PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
April 1, 2023JCO Clinical Cancer Informatics9 citationsOpen Access

Risk Factors of Hyperglycemia After Treatment With the AKT Inhibitor Ipatasertib in the Prostate Cancer Setting: A Machine Learning–Based Investigation

RHRashed HarunRSRucha SaneKYKenta Yoshida

Key Points

Key points are not available for this paper at this time.

Abstract

The findings support using patients' prediabetic status as a key factor for hyperglycemia monitoring and/or trial exclusion criteria. Additionally, the model and relationships between explanatory variables and HGLY ≥2 described herein can help identify patients at high risk for hyperglycemia and develop rational risk mitigation strategies.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Harun et al. (2023) studied this question.

synapsesocial.com/papers/69df12ceb46aaead81614236https://doi.org/10.1200/cci.22.00168
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Regulation of Glucose Homeostasis by Glucocorticoids2015 · 721 citations
  2. 2Abiraterone acetate and prednisone in chemotherapy-naïve prostate cancer patients: rationale, evidence and clinical utility2017 · 23 citations
  3. 3The Evaluation of Serum Amylase in the Patients of Type 2 Diabetes Mellitus, with a Possible Correlation with the Pancreatic Functions2013 · 56 citations
  4. 4Encyclopedia of Machine Learning2010 · 3,486 citations
  5. 5Inhibition of the PI3K/AKT/mTOR Pathway in Solid Tumors2016 · 494 citations